JP2022514695A5 - - Google Patents
Info
- Publication number
- JP2022514695A5 JP2022514695A5 JP2021536077A JP2021536077A JP2022514695A5 JP 2022514695 A5 JP2022514695 A5 JP 2022514695A5 JP 2021536077 A JP2021536077 A JP 2021536077A JP 2021536077 A JP2021536077 A JP 2021536077A JP 2022514695 A5 JP2022514695 A5 JP 2022514695A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- approximately
- use according
- rtx
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862784650P | 2018-12-24 | 2018-12-24 | |
| US62/784,650 | 2018-12-24 | ||
| US201962914170P | 2019-10-11 | 2019-10-11 | |
| US62/914,170 | 2019-10-11 | ||
| PCT/US2019/068235 WO2020139797A1 (en) | 2018-12-24 | 2019-12-23 | Methods for treating parkinson's disease by administering resiniferatoxin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022514695A JP2022514695A (ja) | 2022-02-14 |
| JP2022514695A5 true JP2022514695A5 (https=) | 2023-01-05 |
| JP7519359B2 JP7519359B2 (ja) | 2024-07-19 |
Family
ID=71126251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536077A Active JP7519359B2 (ja) | 2018-12-24 | 2019-12-23 | レシニフェラトキシンを投与することによってパーキンソン病を処置するための方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12201608B2 (https=) |
| EP (1) | EP3902539B1 (https=) |
| JP (1) | JP7519359B2 (https=) |
| KR (1) | KR20210107086A (https=) |
| CN (1) | CN113473983B (https=) |
| AU (1) | AU2019414329A1 (https=) |
| CA (1) | CA3124499A1 (https=) |
| WO (1) | WO2020139797A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210108979A (ko) | 2018-12-21 | 2021-09-03 | 소렌토 쎄라퓨틱스, 인코포레이티드 | 부적응 통증을 치료하기 위한 레시니페라톡신의 신경 주위 투여 |
| US11447444B1 (en) | 2019-01-18 | 2022-09-20 | Centrexion Therapeutics Corporation | Capsaicinoid prodrug compounds and their use in treating medical conditions |
| US11254659B1 (en) | 2019-01-18 | 2022-02-22 | Centrexion Therapeutics Corporation | Capsaicinoid prodrug compounds and their use in treating medical conditions |
| JP7530365B2 (ja) | 2019-01-22 | 2024-08-07 | ソレント・セラピューティクス・インコーポレイテッド | レシニフェラトキシンを投与することによって変形性関節症疼痛を処置するための方法 |
| CA3219312A1 (en) * | 2021-05-18 | 2022-11-24 | Alexis Nahama | Presurgical perineural administration of resiniferatoxin for reduction of post-operative pain |
| WO2025153517A1 (en) | 2024-01-15 | 2025-07-24 | Grünenthal GmbH | Treating knee joint pain by injecting resiniferatoxin at ultra low doses |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2187193B (en) | 1986-02-27 | 1989-11-08 | Gerald Scott | Controllably and swiftly degradable polymer compositions and films and other products made therefrom |
| US5021450A (en) | 1989-05-30 | 1991-06-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof |
| US5232684A (en) | 1990-06-29 | 1993-08-03 | The United States Of America As Represented By The Department Of Health And Human Services | Labelled resiniferatoxin, compositions thereof, and methods for using the same |
| MXPA05006670A (es) * | 2002-12-18 | 2005-10-19 | Algorx Pharmaceuticals Inc | Administracion de capsaicinoides. |
| WO2008109026A1 (en) | 2007-03-05 | 2008-09-12 | Mt Cook Pharma | Pharmaceutical compositions for the localized treatment of neurogenic dysfunction |
| DK2222289T3 (da) * | 2007-11-19 | 2013-10-07 | Nestec Sa | Behandling af oral pharyngeal dysphagi |
| US9956166B2 (en) * | 2013-09-18 | 2018-05-01 | Sorrento Therapeutics, Inc. | Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin |
| CN105017155B (zh) * | 2014-04-16 | 2017-06-16 | 华东师范大学 | 类三环二萜并吡唑衍生物及其制备方法和应用 |
| CA2985235A1 (en) * | 2015-05-07 | 2016-11-10 | Shire Human Genetic Therapies, Inc. | Glucocerebrosidase gene therapy for parkinson's disease |
| PT3302454T (pt) * | 2015-05-26 | 2021-04-01 | Technophage Investig E Desenvolvimento Em Biotecnologia Sa | Composições para utilização no tratamento da doença de parkinson e distúrbios associados |
| CN107126445A (zh) * | 2017-04-20 | 2017-09-05 | 江南大学 | 粪菌移植在治疗帕金森病方面的应用 |
-
2019
- 2019-12-23 WO PCT/US2019/068235 patent/WO2020139797A1/en not_active Ceased
- 2019-12-23 JP JP2021536077A patent/JP7519359B2/ja active Active
- 2019-12-23 KR KR1020217023429A patent/KR20210107086A/ko not_active Ceased
- 2019-12-23 CN CN201980092939.6A patent/CN113473983B/zh active Active
- 2019-12-23 CA CA3124499A patent/CA3124499A1/en active Pending
- 2019-12-23 EP EP19904905.7A patent/EP3902539B1/en active Active
- 2019-12-23 AU AU2019414329A patent/AU2019414329A1/en not_active Abandoned
-
2021
- 2021-06-11 US US17/345,641 patent/US12201608B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022514695A5 (https=) | ||
| JP4463687B2 (ja) | 腹膜透析法 | |
| HU197840B (en) | Process for producing synergic pharmaceutical compositions comprising amantadin and selegilin | |
| CN108495619A (zh) | 棘霉素制剂及其制备方法和使用方法 | |
| JP2008517063A (ja) | Ａ２ａアデノシンレセプターアゴニストの使用 | |
| JP2021107464A (ja) | 眼科組成物 | |
| JP5977919B2 (ja) | 医薬用組成物 | |
| Krasnopolskii et al. | Technologies and perspectives of liposomal drug application in clinical practice | |
| CN116942662A (zh) | 麦角硫因(egt)预防和治疗脓毒症的用途 | |
| JP7400180B2 (ja) | 非経口製剤及びその使用 | |
| Galanello | Iron chelation: new therapies | |
| CN115120724A (zh) | 治疗再生障碍性贫血的方法和药物组合物 | |
| JP2017533252A (ja) | Ｃ型肝炎のための長時間作用型医薬組成物 | |
| JP2003516962A (ja) | 視神経損傷および網膜損傷の処置のためのアデノシンキナーゼのインヒビター | |
| JP2025510725A5 (https=) | ||
| Newland | Emerging strategies to treat chronic immune thrombocytopenic purpura | |
| KR20050054921A (ko) | 저알부민 상태의 개선제 | |
| JP2022136242A (ja) | エピナスチン又はその塩を含有する花粉破裂抑制剤 | |
| JPH11171763A (ja) | 肝疾患治療剤 | |
| CN1122534C (zh) | 减少药物副作用的方法 | |
| JPH0759507B2 (ja) | 骨髄異形成症候群治療剤 | |
| JPH08165236A (ja) | 下痢の予防及び治療剤 | |
| US11957701B2 (en) | Therapy and new therapeutic agent for blood cancer | |
| TW202023568A (zh) | 用於治療癌症之組合療法 | |
| Koren et al. | Developmental pharmacology of aminoglycosides and vancomycin |